Has Alice Maher, MD received payments from drug or device companies?

Yes. Drug and device makers reported $204 in general payments to Alice Maher, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Alice Maher, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Alice Maher, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Alice Maher, MD

Psychiatry · New York, NYNPI 1548331820

Payments from drug & device makers

$204in general payments, 2019–2025

Across 8 payments — averaging $25.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$145
Sunovion Pharmaceuticals Inc.$58

What the payments were for

Food & beverage$204100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	3	$145
Sunovion Pharmaceuticals Inc.	5	$58

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$125

How this compares

$204 in reported general payments places this provider in the 55th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$322,476

Medicare patients

Services billed

3,932

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bupropion XlBupropion Hcl	76	$2,318
Mirtazapine	32	$1,386
Duloxetine Hcl	27	$791
Fluoxetine Hcl	36	$786
Escitalopram Oxalate	69	$644
Clonazepam	99	$599
Lorazepam	39	$456
Sertraline Hcl	30	$443
Trazodone Hcl	51	$405
Aripiprazole	17	$390
Venlafaxine Hcl ErVenlafaxine Hcl	33	$376
Quetiapine Fumarate	42	$366
Paroxetine Hcl	22	$345
Zolpidem Tartrate	71	$287
Bupropion Hcl	15	$265

Paid to pharmacies, not to this prescriber.

Other psychiatry in New York

Michael LiebowitzNew York$7.1M
Paul EderNew York$2.7M
Lenard AdlerNew York$1.8M
Ram ShrivastavaNew York$1.8M
Jonathan KaneNew York$1.8M
Eric HollanderNew York$1.4M
William HapworthNew York$1.3M
Manish ZinzuvadiaNew York$1.3M
Jianping ChenNew York$1.2M
Anthony ZoghbiNew York$1.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →